| The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries | journal | July 2005 | 
    | Expressed antibody repertoires in human cord blood cells: 454 sequencing and IMGT/HighV-QUEST analysis of germline gene usage, junctional diversity, and somatic mutations | journal | December 2011 | 
    | Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogens | journal | December 2009 | 
    | Multidonor Analysis Reveals Structural Elements, Genetic Determinants, and Maturation Pathway for HIV-1 Neutralization by VRC01-Class Antibodies | journal | August 2013 | 
    | Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections | journal | February 2015 | 
    | Junctional Amino Acids Determine the Maturation Pathway of an Antibody | journal | September 1999 | 
    | Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study | journal | October 2013 | 
    | Spiking the MERS-coronavirus receptor | journal | August 2013 | 
    | Structural and genetic basis for development of broadly neutralizing influenza antibodies | journal | August 2012 | 
    | Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC | journal | March 2013 | 
    | B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study | journal | May 2012 | 
    | A decade after SARS: strategies for controlling emerging coronaviruses | journal | November 2013 | 
    | Emerging Human Coronaviruses — Disease Potential and Preparedness | journal | November 2012 | 
    | Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus | journal | August 2013 | 
    | Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120 | journal | February 2004 | 
    | Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies | journal | July 2007 | 
    | Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus | journal | August 2014 | 
    | Structure of Severe Acute Respiratory Syndrome Coronavirus Receptor-binding Domain Complexed with Neutralizing Antibody | journal | April 2006 | 
    | Phaser crystallographic software | journal | July 2007 | 
    | PHENIX : building new software for automated crystallographic structure determination | journal | October 2002 | 
    | Coot model-building tools for molecular graphics | journal | November 2004 | 
    | The CCP4 suite programs for protein crystallography | journal | September 1994 | 
    | Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 | journal | July 2010 | 
    | Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses | journal | July 2012 | 
    | Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors | journal | March 2013 | 
    | Expanding the breadth of an HIV-1 vaccine | journal | December 2014 | 
    | Receptor Variation and Susceptibility to Middle East Respiratory Syndrome Coronavirus Infection | journal | February 2014 | 
    | Exceptionally Potent Neutralization of Middle East Respiratory Syndrome Coronavirus by Human Monoclonal Antibodies | journal | April 2014 | 
    | Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans | journal | November 2012 | 
    | Crystal Structure of the Hendra Virus Attachment G Glycoprotein Bound to a Potent Cross-Reactive Neutralizing Human Monoclonal Antibody | journal | October 2013 | 
    | Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution | text | January 2014 | 
    | MolProbity: all-atom contacts and structure validation for proteins and nucleic acids | text | January 2007 | 
    | Middle East Respiratory Syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013 | journal | December 2013 | 
    | Reconstructing a B-Cell Clonal Lineage. II. Mutation, Selection, and Affinity Maturation | journal | April 2014 | 
    | Origin, diversity, and maturation of human antiviral antibodies analyzed by high-throughput sequencing | journal | January 2012 | 
    | The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries | journal | July 2005 | 
    | The COVID-19 Vaccine Landscape | book | January 2021 | 
    | Expressed antibody repertoires in human cord blood cells: 454 sequencing and IMGT/HighV-QUEST analysis of germline gene usage, junctional diversity, and somatic mutations | journal | December 2011 | 
    | [20] Processing of X-ray diffraction data collected in oscillation mode | book | January 1997 | 
    | Junctional Amino Acids Determine the Maturation Pathway of an Antibody | journal | September 1999 | 
    | Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study | journal | October 2013 | 
    | Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogens | journal | December 2009 | 
    | Multidonor Analysis Reveals Structural Elements, Genetic Determinants, and Maturation Pathway for HIV-1 Neutralization by VRC01-Class Antibodies | journal | August 2013 | 
    | Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections | journal | February 2015 | 
    | Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4 | journal | July 2013 | 
    | Structural and genetic basis for development of broadly neutralizing influenza antibodies | journal | August 2012 | 
    | Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC | journal | March 2013 | 
    | Rapid development of broadly influenza neutralizing antibodies through redundant mutations | journal | October 2014 | 
    | B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study | journal | May 2012 | 
    | IMGT/HighV QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling | journal | September 2013 | 
    | Evaluation of candidate vaccine approaches for MERS-CoV | journal | July 2015 | 
    | A decade after SARS: strategies for controlling emerging coronaviruses | journal | November 2013 | 
    | Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses | journal | February 2009 | 
    | Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia | journal | November 2012 | 
    | Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus | journal | August 2013 | 
    | Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120 | journal | February 2004 | 
    | Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies | journal | July 2007 | 
    | Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution | journal | April 2014 | 
    | Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus | journal | August 2014 | 
    | Structure of Severe Acute Respiratory Syndrome Coronavirus Receptor-binding Domain Complexed with Neutralizing Antibody | journal | April 2006 | 
    | MolProbity: all-atom contacts and structure validation for proteins and nucleic acids | journal | May 2007 | 
    | IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis | journal | May 2008 | 
    | Phaser crystallographic software | journal | July 2007 | 
    | PHENIX : building new software for automated crystallographic structure determination | journal | October 2002 | 
    | Coot model-building tools for molecular graphics | journal | November 2004 | 
    | The CCP4 suite programs for protein crystallography | journal | September 1994 | 
    | Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 | journal | July 2010 | 
    | Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing | journal | August 2011 | 
    | Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses | journal | July 2012 | 
    | Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors | journal | March 2013 | 
    | Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies | journal | December 2014 | 
    | Transepithelial Transport of Fc-Targeted Nanoparticles by the Neonatal Fc Receptor for Oral Delivery | journal | November 2013 | 
    | Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein | journal | April 2014 | 
    | Therapeutic Treatment of Nipah Virus Infection in Nonhuman Primates with a Neutralizing Human Monoclonal Antibody | journal | June 2014 | 
    | Receptor Variation and Susceptibility to Middle East Respiratory Syndrome Coronavirus Infection | journal | February 2014 | 
    | Exceptionally Potent Neutralization of Middle East Respiratory Syndrome Coronavirus by Human Monoclonal Antibodies | journal | April 2014 | 
    | Genetic Characterization of Betacoronavirus Lineage C Viruses in Bats Reveals Marked Sequence Divergence in the Spike Protein of Pipistrellus Bat Coronavirus HKU5 in Japanese Pipistrelle: Implications for the Origin of the Novel Middle East Respiratory Syndrome Coronavirus | journal | May 2013 | 
    | Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans | journal | November 2012 | 
    | Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs | journal | January 2013 | 
    | Crystal Structure of the Hendra Virus Attachment G Glycoprotein Bound to a Potent Cross-Reactive Neutralizing Human Monoclonal Antibody | journal | October 2013 | 
    | Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution | text | January 2014 | 
    | Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus | text | January 2014 | 
    | MolProbity: all-atom contacts and structure validation for proteins and nucleic acids | text | January 2007 | 
    | A decade after SARS: strategies for controlling emerging coronaviruses | text | January 2013 | 
    | Middle East Respiratory Syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013 | journal | December 2013 | 
    | Middle East Respiratory Syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013 | journal | December 2013 | 
    | Reconstructing a B-Cell Clonal Lineage. II. Mutation, Selection, and Affinity Maturation | journal | April 2014 | 
    | Origin, diversity, and maturation of human antiviral antibodies analyzed by high-throughput sequencing | journal | January 2012 | 
    | Cross-Reactive Human IgM-Derived Monoclonal Antibodies that Bind to HIV-1 Envelope Glycoproteins | journal | February 2010 | 
    | Therapeutic antibodies, vaccines and antibodyomes | journal | May 2010 | 
    | Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs | text | January 2013 |